- Home
- CLDI vs MMA Comparison
CLDI vs MMA Comparison
Compare CLDI & MMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDI
- MMA
- Stock Information
- Founded
- CLDI 2014
- MMA 2013
- Country
- CLDI United States
- MMA Australia
- Employees
- CLDI N/A
- MMA N/A
- Industry
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- MMA
- Sector
- CLDI Health Care
- MMA
- Exchange
- CLDI Nasdaq
- MMA Nasdaq
- Market Cap
- CLDI 14.0M
- MMA 15.9M
- IPO Year
- CLDI N/A
- MMA 2024
- Fundamental
- Price
- CLDI $0.48
- MMA $0.88
- Analyst Decision
- CLDI Strong Buy
- MMA
- Analyst Count
- CLDI 2
- MMA 0
- Target Price
- CLDI $15.00
- MMA N/A
- AVG Volume (30 Days)
- CLDI 386.9K
- MMA 2.6M
- Earning Date
- CLDI 05-13-2025
- MMA 01-21-2025
- Dividend Yield
- CLDI N/A
- MMA N/A
- EPS Growth
- CLDI N/A
- MMA N/A
- EPS
- CLDI N/A
- MMA N/A
- Revenue
- CLDI N/A
- MMA $375,175.00
- Revenue This Year
- CLDI N/A
- MMA N/A
- Revenue Next Year
- CLDI N/A
- MMA N/A
- P/E Ratio
- CLDI N/A
- MMA N/A
- Revenue Growth
- CLDI N/A
- MMA 45.19
- 52 Week Low
- CLDI $0.35
- MMA $0.60
- 52 Week High
- CLDI $4.90
- MMA $5.00
- Technical
- Relative Strength Index (RSI)
- CLDI 38.44
- MMA N/A
- Support Level
- CLDI $0.41
- MMA N/A
- Resistance Level
- CLDI $0.45
- MMA N/A
- Average True Range (ATR)
- CLDI 0.07
- MMA 0.00
- MACD
- CLDI 0.02
- MMA 0.00
- Stochastic Oscillator
- CLDI 56.57
- MMA 0.00
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.
About MMA Alta Global Group Limited
Mixed Martial Arts Group Ltd formerly Alta Global Group Ltd is a technology company engaged in the provision and administration of mixed martial arts training programs, and gym programs. It provides subscription-based products and services, offering both B2B SaaS solutions and B2C products and programs, covering online engagement, online content, and immersive in-gym experiences. The company's business units are; Trainalta.com; Mixed Martial Arts.com; and Hype.Co, Mobile Marketing solution. Its Alta Platform serves as a comprehensive solution for martial arts and combat sports, offering a blend of four core products: the Warrior Training Program, UFC Fight Fit Program, Alta Academy, and the Alta Community.